exist. The goal of this study was to compare the real-world performance of SAVGs and IAAVGs.
Author Disclosures: A. N. Abou Ali: Nothing to disclose; E. Avgerinos: Nothing to disclose; R. Chaer: Nothing to disclose; E. Dillavou: BTG and Vascular Insights: consulting fees (eg, advisory boards); U. P. Nag: Nothing to disclose; S. Truong: Nothing to disclose; J. K. Wagner: Nothing to disclose; T. H. Yuo: Nothing to disclose. Background: In this video, we present the radial artery deviation and reimplantation (RADAR) technique of arteriovenous fistula creation. This technique has been developed in order to avoid the dissection and mobilization of the vein, therefore reducing juxta-anastomotic stenosis. We emphasize the surgical tricks that may help other surgeons reproduce the technique and obtain good outcomes.
VS06. The RADAR Technique of Arteriovenous Fistula Creation
http://www.conferenceabstracts.com/uploads/cfp2/attachments/ZRFDQ HCR/ZRFDQHCR-289860-1-ANY.mp4
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IP001.
Hybrid Fenestrated Repair of a Juxtarenal Aneurysm With Congenital Pelvic Kidney
Mathew Wooster, Martin Back. University of South Florida, Tampa, Fla
Objectives: Since its first description, fenestrated endovascular repairs for paravisceral abdominal aortic aneurysms have become widely popularized. The only currently commercially available device in the United States, however, remains the Cook Zenith Fenestrated device, which continues to have multiple anatomic restraints to its possible configurations. Beyond the average restraints, congenital visceral arterial anomalies can make endovascular repair particularly cumbersome. We present here such a case in which a patient with a congenital pelvic kidney not amenable to endovascular repair with a custom fenestrated device was able to be treated with one using preoperative surgical debranching.
Methods: A 65-year-old man was found to have a 5.5-cm pararenal aortic aneurysm complicated by a congenital left pelvic kidney with a normal anatomic configuration of his right kidney. Evaluation for open vs endovascular repair was significant for chronic obstructive pulmonary disease, severe coronary disease status postmultivessel bypass, and associated heart failure with ejection fraction <20%, with small areas of reversible ischemia and expected daily functional inhibition. Given his poor cardiac reserve, he was deemed too high risk for direct aortic repair with suprarenal or supraceliac cross-clamp unlikely to be tolerated, with a Vascular Quality Initiative risk score suggesting 15% risk of perioperative myocardial infarction. However, his variant renal artery anatomy precluded him from standard endovascular repair. Ultimately, he was offered debranching of his pelvic renal artery with interval custom Zenith fenestrated endograft repair.
Results: Renal artery debranching was performed via a midline incision to expose the distal aorta and right common iliac artery. A 6-mm heparin-bonded polytetrafluoroethylene conduit was used to create bypass from the right common iliac artery to the pelvic renal artery. Estimated blood loss was 400 mL, with an operative time of 2 hours. His recovery was uneventful, discharging home on postoperative day 5. He returned 8 weeks later for planned endovascular completion of his repair. A custom 32-Â 94-mm Zfen device with right renal fenestration and large superior mesenteric artery scallop was deployed. A 7-Â 22-mm iCAST renal stent and 9-Â 25-mm Express superior mesenteric artery stent completed the repair. Total fluoroscopy time was 29 minutes, with 95 mL of iodinated contrast usage. His postoperative course was again uneventful, and now 1 year out, has a stable aneurysm sac without endoleak and patent renal/mesenteric arteries by computed tomography angiogram and renal duplex ultrasound imaging.
Conclusions: Congenital pelvic kidney represents a unique anatomic limitation to aortic aneurysm repair. Creative combinations of open and endovascular therapy can be used to treat even high-medical-risk patients.
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IP003. Racial Disparities in Endovascular Aortic Aneurysm Repair
Adam Tanious, Nirmani Karunathilake, Joel Toro, Afif Hanna, Timothy Fawcett, Brian Graves, Peter Nelson. University of South Florida, Tampa, Fla
Objectives: Racial and ethnic disparities are a critical issue in access to care within all fields of medicine. Techniques and devices for endovascular aortic aneurysm repair (EVAR) have improved significantly, allowing the safe, minimally invasive treatment of more complex anatomies by a wider array of practitioners. We hypothesized that analysis of a statewide administrative data set would demonstrate disparities based on race with respect to access to this latest technology and the associated outcomes following EVAR.
Methods: Using deidentified data from the Florida State Agency for Health Care Administration, we identified patients based on International Classification of Diseases-Ninth Revision procedure codes who underwent EVAR between the years 2000 and 2014. We then assigned these procedures with the specialty of the operating physician and then analyzed outcomes based on the race of the patient defined within the following groups: non-Hispanic white, non-Hispanic black, Hispanic, Asian, and other. We also analyzed differences in insurance/payer data. We then stratified patients and patient outcomes based on the classification of the practitioner performing the surgery.
Results: We identified 36,601 EVAR procedures during the study period. The average age of the total sample was 73.38 6 9.87 years, with 81.2% (n ¼ 29,034) of the cohort being male. Breakdown of patients within each race category was as follows: 17,056 non-Hispanic whites (47.7%), 1630 non-Hispanic African Americans (4.6%), 16,431 Hispanics(46.0%), and 632 patients (1.8%) identified as "other." An analysis of the differences between racial groups in demographic/background data showed significant differences between age at presentation, sex of patient, and comorbidity score of patients at presentation. There were significant differences in outcomes based on race with respect to total hospital charges, length of stay, and disposition. The Table shows the breakdown of the above analysis with associated significance values. Significant differences were also found in the payer status based of each racial group. There were 1786 practitioners who completed 35,749 EVARs where both practitioner and race data were available. Stratifying by type of practitioner treating, we also found significant differences in the type of practitioner treating the various racial groups as well as the academic status of the practitioner.
Conclusions: Racial disparities were discovered with respect to EVAR treatment. African Americans present at younger ages, have the highest percentage of females requiring intervention, have the longest hospital stays, have the highest Medicaid payer source, and have the highest in-hospital total charges of any racial group. Hispanics present with the highest comorbidity scores as compared to their counterparts.
Author Disclosures: T. Fawcett: Nothing to disclose; B. Graves: Nothing to disclose; A. Hanna: Nothing to disclose; N. Karunathilake: Nothing to disclose; P. Nelson: Nothing to disclose; A. Tanious: Nothing to disclose; J. Toro: Nothing to disclose. Objectives: Infected aortic grafts involving the bowel call for concomitant vascular and general surgical skills. We sought to understand the outcomes of bowel surgery when performed by dedicated bowel surgeons as compared to vascular surgeons trained in general surgery for the treatment of infected aortic grafts.
Methods: From 2002 to 2015, patients were selected using Current Procedural Terminology codes for excision of infected abdominal grafts as well as repair of graft-enteric fistulas that required concomitant bowel surgery. Surgeons were grouped by vascular surgeons or bowel surgeons (including general, trauma, and colorectal surgeons). Patient comorbidities, hospitalization data, and follow-up were analyzed with univariate and multivariate regression analysis.
Results: Forty-four patients were treated for infected grafts with concomitant bowel involvement during the time frame studied. Eighty-one percent were male with a mean age of 75 6 10, an average time to presentation of 7.9 6 5.8 years, and a mean follow-up time of 2.4 6 2.9 years. The in-hospital mortality for this cohort was 30% (n ¼ 13). Arterial reconstruction occurred at the index procedure 51% of the time, with the most common arterial repair being an extra-anatomic bypass (n ¼ 35). Vascular surgeons performed their own bowel repair in 62% of index cases for this cohort (n ¼ 26). Looking specifically at the repairs performed, bowel surgeons were required to operate on multiple segments of the bowel in 50% of cases, while vascular surgeons had single bowel-segment injuries in 80% of cases (P ¼ .0489). More than half of the bowel repairs by vascular surgeons were primary bowel repairs (56%), whereas bowel surgeons performed repairs requiring resections and anastomosis in 67% of their patients (P ¼ .2). Vascular surgeons did have an overall higher bowel complication rate as compared to nonvascular surgeons (30% vs 18%), although it was 
